These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7702112)

  • 21. Cost-effectiveness of emergency contraception options over 1 year.
    Bellows BK; Tak CR; Sanders JN; Turok DK; Schwarz EB
    Am J Obstet Gynecol; 2018 May; 218(5):508.e1-508.e9. PubMed ID: 29409847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimates of pregnancies averted through California's family planning waiver program in 2002.
    Foster DG; Biggs MA; Amaral G; Brindis C; Navarro S; Bradsberry M; Stewart F
    Perspect Sex Reprod Health; 2006 Sep; 38(3):126-31. PubMed ID: 16963385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IUDs, implants, Depo-Provera have "incredible return on investment".
    Contracept Technol Update; 1995 Jul; 16(7):81-4. PubMed ID: 12346506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceived and insurance-related barriers to the provision of contraceptive services in U.S. abortion care settings.
    Kavanaugh ML; Jones RK; Finer LB
    Womens Health Issues; 2011; 21(3 Suppl):S26-31. PubMed ID: 21530835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contraceptive delivery in the developing world.
    Potts DM; Crane SF
    Br Med Bull; 1993 Jan; 49(1):27-39. PubMed ID: 8324614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic Burden of Contraception Management in Spain.
    Parra Ribes I; Rascón Poza JJ; Pérez Campos E; Bugella Yudice I; Rodríguez Domingo MJ
    J Health Econ Outcomes Res; 2018; 6(1):63-74. PubMed ID: 32685572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of social marketing on contraceptive prevalence and cost in Honduras.
    Janowitz B; Suazo M; Fried DB; Bratt JH; Bailey PE
    Stud Fam Plann; 1992; 23(2):110-7. PubMed ID: 1604457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
    Mavranezouli I;
    Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scaling Up Family Planning to Reduce Maternal and Child Mortality: The Potential Costs and Benefits of Modern Contraceptive Use in South Africa.
    Chola L; McGee S; Tugendhaft A; Buchmann E; Hofman K
    PLoS One; 2015; 10(6):e0130077. PubMed ID: 26076482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Historical survey of modern reversible contraceptive methods].
    Mbabajende V
    Imbonezamuryango; 1986 Apr; (5):14-7. PubMed ID: 12268230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicaid spending on contraceptive coverage and pregnancy-related care.
    Laliberté F; Lefebvre P; Law A; Duh MS; Pocoski J; Lynen R; Darney P
    Reprod Health; 2014 Mar; 11(1):20. PubMed ID: 24581033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New IPPF statement on breastfeeding, fertility and post-partum contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. U.S. agencies providing publicly funded contraceptive services in 1999.
    Finer LB; Darroch JE; Frost JJ
    Perspect Sex Reprod Health; 2002; 34(1):15-24. PubMed ID: 11990635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptability of IUDs is increasing.
    Finger WR; Barr D
    Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth.
    Fu H; Darroch JE; Haas T; Ranjit N
    Fam Plann Perspect; 1999; 31(2):56-63. PubMed ID: 10224543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Contraceptive development--the view from the U.S.A. in the mid 80s].
    Potts M; Siemens A; Burton N
    Contracept Fertil Sex (Paris); 1986 Mar; 14(3):247-51. PubMed ID: 12268061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
    Gariepy AM; Duffy JY; Xu X
    Obstet Gynecol; 2015 Jul; 126(1):47-55. PubMed ID: 26241255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The provision and funding of contraceptive services at publicly funded family planning agencies: 1995-2003.
    Lindberg LD; Frost JJ; Sten C; Dailard C
    Perspect Sex Reprod Health; 2006 Mar; 38(1):37-45. PubMed ID: 16554270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The costs of contraception.
    Torres A; Forrest JD
    Fam Plann Perspect; 1983; 15(2):70-2. PubMed ID: 6671479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.